|
⚲
|
| Keyboard |
| Eric Bednarski | |
|---|---|
| Firm | MVM Partners LLC |
| Address | c/o Mvm J LP Old City Hall, 45 School Street Boston, MA 02108 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| MVM Partners LLC | |||||
| MVM E LP | 021-467795 | Director | 7.2 M | ||
| MVM F LP | 021-467798 | Director | 0.2 M | ||
| MVM VI LP | 021-464501 | Director | 259.9 M | 577.0 M | |
| MVM J LP | 021-537329 | Executive Officer | |||
| MVM K LP | 021-537326 | Executive Officer | |||
| Optinose Inc | 021-513751 | Director | 4.7 M of 4.7 M |
||
| Neurolens Inc | 021-458709 | Director | 67.6 M of 67.6 M |
||
| Mdxhealth Sa | 021-455935 | Director | 5.0 M | ||
| VERO Biotech Inc | 021-426342 | Director | 27.3 M of 99.5 M |
||
| Tarsa Therapeutics Inc | 021-291370 | Director | 0.5 M of 1.0 M |
||
| Tarsa Therapeutics Inc | 021-278462 | Director | 1.6 M of 1.6 M |
||
| Accuvein Inc | 021-275584 | Director | 2.5 M of 9.1 M |
||
| Tarsa Therapeutics Inc | 021-266953 | Director | 1.2 M of 1.2 M |
||
| Tarsa Therapeutics Inc | 021-257818 | Director | 2.0 M of 2.0 M |
||
| Biotheranostics Inc | 021-256767 | Director | 20.0 M of 32.0 M |
||
| SOLX Inc | 021-247437 | Director | 2.2 M of 11.0 M |
||
| SOLX Inc | 021-208279 | Director | 2.1 M of 4.8 M |
||
| Tarsa Therapeutics Inc | 021-175388 | Director | 13.8 M of 28.0 M |
||
| SOLX Inc | 021-172171 | Director | 3.2 M of 9.0 M |
||
| Accuvein Inc | 021-163829 | Director | 23.5 M of 23.5 M |
||
| Prexa Pharmaceuticals Inc | 021-159077 | Director | 3.3 M of 7.0 M |
||
| SOLX Inc | 021-149659 | Director | 3.7 M of 7.2 M |
||
| Tarsa Therapeutics Inc | 021-148747 | Director | 15.5 M of 24.5 M |
||
| Ampla Pharmaceuticals Inc | 021-96858 | Director | 3.6 M of 5.4 M |
||
| Tarsa Therapeutics Inc | 021-135603 | Director | 12.1 M of 24.1 M |
||
| MVM Partners LLP | |||||
| MVM IV LP | 021-224965 | Executive Officer | 27.0 M | 123.6 M | |
| Related People Network |
|---|
| Network #470 at Optinose Inc — files alongside 10 co-filers |